Adage Capital Partners GP »

Moonlake Immunot shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2024-03-31 $115M 2.3M 50.23
2023-09-30 $111M 2.0M 57.00
2023-06-30 $70M 1.4M 51.00
2023-03-31 $36M 1.7M 21.39

More positions owned by Adage Capital Partners GP

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Hess (HES)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Tesla Motors (TSLA)
Merck & Co (MRK)
Abbvie (ABBV)

View all positions for Adage Capital Partners GP

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
T. Rowe Price Associates
Citadel Advisors
Holocene Advisors
Goldman Sachs Group
Westfield Capital Management Company
Marshall Wace
Federated Investors
Alliancebernstein
Paradigm Biocapital Advisors
Logos Global Management
Fred Alger Management
Balyasny Asset Management
Nuveen Asset Management

View all funds holding Moonlake Immunot